PANCREATIC BETA-CELLS IN INSULIN-DEPENDENT DIABETES

[1] Gepts W, Pathologic anatomy of the pancreas in juvenile diabetes mellitus, Diabetes, 14, pp. 619-633, (1965)

[2] Rossini A, Mordes JC, Like AA, Immunology of insulin‐dependent diabetes mellitus, Annu Rev Immunol, 3, pp. 289-320, (1985)

[3] Eisenbarth GS, Type 1 diabetes mellitus. A chronic autoimmune disease, N Engl J Med, 314, pp. 1360-1368, (1986)

[4] Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho, Folli F, Richter-Olesen H, De Camilli P, Identification of the 64 K autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase, Nature, 347, pp. 151-156, (1990)

[5] Clare-Salzler MJ, Tobin AJ, Kaufman DL, Glutamate decarboxylase: an autoantigen in IDDM, Diabetes Care, 15, pp. 132-135, (1992)

[6] Cooke A, An overview on possible mechanism of destruction of the insulin‐producing beta cell, Microbiol Immunol, 164, pp. 125-142, (1990)

[7] Bonifacio E, Bingley P, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF, Quantification of islet‐cell antibodies and prediction of insulin‐dependent diabetes, Lancet, 335, pp. 147-149, (1990)

[8] Sigurdsson E, Baekkeskov S, The 64‐kDA beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin‐dependent diabetes mellitus, Microbiol Immunol, 164, pp. 143-168, (1990)

[9] Harrison LC, Campbell IL, Colman PG, Chosich N, Kay TWH, Tait BD, Bartholomeusz RK, De Aizpurua HJ, Joseph JL, Chu S, Kielezynski WE, Type 1 diabetes: immunopathology and immunotherapy, Adv Endocrinol Metab, 1, pp. 36-94, (1990)

[10] Atkinson MA, Maclaren NK, What causes diabetes?, Sci Am, 263, pp. 62-63, (1990)

[1] Gepts W, Pathologic anatomy of the pancreas in juvenile diabetes mellitus, Diabetes, 14, pp. 619-633, (1965)

[2] Rossini A, Mordes JC, Like AA, Immunology of insulin‐dependent diabetes mellitus, Annu Rev Immunol, 3, pp. 289-320, (1985)

[3] Eisenbarth GS, Type 1 diabetes mellitus. A chronic autoimmune disease, N Engl J Med, 314, pp. 1360-1368, (1986)

[4] Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho, Folli F, Richter-Olesen H, De Camilli P, Identification of the 64 K autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase, Nature, 347, pp. 151-156, (1990)

[5] Clare-Salzler MJ, Tobin AJ, Kaufman DL, Glutamate decarboxylase: an autoantigen in IDDM, Diabetes Care, 15, pp. 132-135, (1992)

[6] Cooke A, An overview on possible mechanism of destruction of the insulin‐producing beta cell, Microbiol Immunol, 164, pp. 125-142, (1990)

[7] Bonifacio E, Bingley P, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF, Quantification of islet‐cell antibodies and prediction of insulin‐dependent diabetes, Lancet, 335, pp. 147-149, (1990)

[8] Sigurdsson E, Baekkeskov S, The 64‐kDA beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin‐dependent diabetes mellitus, Microbiol Immunol, 164, pp. 143-168, (1990)

[9] Harrison LC, Campbell IL, Colman PG, Chosich N, Kay TWH, Tait BD, Bartholomeusz RK, De Aizpurua HJ, Joseph JL, Chu S, Kielezynski WE, Type 1 diabetes: immunopathology and immunotherapy, Adv Endocrinol Metab, 1, pp. 36-94, (1990)

[10] Atkinson MA, Maclaren NK, What causes diabetes?, Sci Am, 263, pp. 62-63, (1990)